← Back to all signals
RESEARCH PAPER ANALYSIS

Clinical Profile, Outcomes, and Predictors of Malignant Pheochromocytoma and Paraganglioma: Insights From a Single-Center Cohort.

AI interpretation is pending for this paper.

Open original publication →
PMID40735853
JournalClinical endocrinology
Publication Date2025-07-30
Ingested2026-08-02 12:04 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Malignant pheochromocytoma and paraganglioma (mPPGL) are not so common and the factors predicting the metastatic behavior are not well understood. METHODS: This retrospective cohort study included 218 patients with PPGL managed at our center over a period of 11 years (2013-2024). The clinical profile and treatment outcomes of patients with mPPGL were studied and were compared with non-metastatic PPGL(non-mPPGL). RESULTS: Thirty-six patients had mPPGL and the median age at diagnosis of metastases was 39.5 years(range 10-62). Twenty-one(58.3%) patients had synchronous metastases and 15(41.7%) developed metachronous metastases after a median duration of 76 months(range 13-270 months) from the diagnosis of the primary tumor. Metastases were detected in 100% of patients who had 18FDG(4/4) and 68 Ga DOTATATE(4/4) PET-CT, 97.2% (35/36) with CT/MRI and 79.3%(23/29) with 131I MIBG scan. Surgery was the primary treatment in 78%, and 131I MIBG therapy was administered to 19(52.8%) patients. Eleven patients succumbed due to metastatic disease and among them nine died within a year of diagnosis of metastases, the median survival at last follow-up was 31.5 months (range 3-96). On comparing mPPGL(n = 36) and non-mPPGL(n = 182), we found that patients with mPPGL had larger tumors (8.8 ± 5.2 vs. 6.3 ± 3.3, p = 0.001), had less frequent adrenergic symptoms and more often had extra-adrenal tumors. CONCLUSION: Malignant PPGLs had a variable clinical course and were amenable to multimodal therapeutic strategies with a favorable outcome in about 67% of the patients. Although mPPGL had larger tumor diameter compared to non-mPPGL, no particular size cut-off could accurately predict metastases. Adjuvant 131I MIBG therapy is a useful treatment option in resource limited settings.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 H1N1-Related Hemophagocytic Lymphohistiocytosis Complicated by Severe Rhabdomyolysis in a Pediatric Patient: A First Case Report. Case reports in pediatrics 50.2 2 Endoscopic diagnosis and management of biliary neuroendocrine tumor with prior Roux-en-Y choledochojejunostomy: a case report. iGIE : innovation, investigation and insights 49.9 3 Dermoscopic and Histopathological Features of Nonfamilial Multiple Trichoepitheliomas: A Case Report. Cureus 49.9 4 Primary Amenorrhea Revealing Adamantinomatous Craniopharyngioma Associated With Central Hypogonadotropic Hypogonadism in an Adolescent Girl: A Case Report. Cureus 49.0 5 From the Thoracic Outlet to the Brachial Plexus: A Rare Presentation of Pediatric Ewing Sarcoma. Cureus 63.1 6 Kimura Disease in an Adolescent With Type 1 Diabetes Mellitus: A Rare Co-occurrence of T Helper 2-Driven Eosinophilic Lymphadenopathy and Autoimmune Endocrinopathy. Cureus 59.1 7 GPR68 Inhibition Induces Ferroptosis in Atypical Teratoid Rhabdoid Tumors. Cancer reports (Hoboken, N.J.) 55.7 8 Predictive value of persistent cerebrospinal fluid antibodies at 12 months for long-term clinical outcomes in pediatric anti-NMDAR encephalitis: a retrospective cohort study. Frontiers in immunology 73.8 9 Case Report: Myelodysplastic changes and 7q deletion in a case of vitamin B12 deficiency: a diagnostic pitfall. Frontiers in nutrition 51.4 10 Predictors of underlying neuroblastoma and neurodevelopmental outcomes in children with opsoclonus-myoclonus syndrome: a retrospective cohort study in China. Frontiers in neurology 74.8 11 Health information literacy mediates the relationship between active information seeking and HPV-related knowledge among female undergraduates: the moderating role of information channel characteristics. Frontiers in public health 62.0 12 The hope of children and families in the context of cancer: a scoping review. Frontiers in pediatrics 73.9 13 Development of novel Copper(II)-hydrazone complexes for targeting the inhibition of human osteosarcoma growth. Frontiers in chemistry 60.2 14 Respiratory Viral Infections in Febrile Children With Lymphoreticular Malignancies: A Single-Centre Descriptive Study. Journal of medical virology 65.4 15 Burden of dermatology outpatient and inpatient services in China, 2011-2023. Frontiers in public health 57.5 16 A case report: axillary ALK-positive anaplastic large-cell lymphoma mimicking an infectious abscess in an adolescent. Frontiers in oncology 56.3 17 Fibrolipomatous Hamartoma of the Median Nerve Misdiagnosed as a Palmar Space Abscess: A Case Report. International medical case reports journal 47.5 18 Multidisciplinary Management of a Giant Ovarian Sertoli-Leydig Cell Tumor Presenting With Isosexual Precocious Puberty: A Pediatric Case Report. Clinical case reports 56.9 19 Pediatric sellar and parasellar lesions: a population-based cohort study of presentation, management, and endocrine outcomes. Pituitary 62.4 20 Burden of CNS neoplasms in the Middle East and North Africa from 1990 to 2023, with projections to 2050: Insights from Global Burden of Disease. Medicine 38.5 21 Epstein-Barr Virus Association and Prognosis in Taiwanese Hodgkin Lymphoma: A Nationwide Multicenter Study With Comparison to United States Whites. International journal of cancer 58.7 22 Multimodal modeling of the ictal onset zone in refractory insular epilepsy and seizure outcome of magnetic resonance-guided laser interstitial therapy: A pediatric single-center retrospective study. Epilepsia 70.26 23 Cancer Treatment During Pregnancy and Maternal and Infant Outcomes: A Descriptive Cohort Study Using a Japanese Claims Database. Pharmacoepidemiology and drug safety 68.14 24 Global epidemiological and genetic burden of rare neurological diseases in children. iScience 56.0 25 Fatal complications in a young adult with large Ewing sarcoma of the chest wall. Radiology case reports 58.4 26 Epidemiology, risk factors and outcomes of Clostridioides difficile infection in a UK district general hospital: a retrospective cohort study. Infection prevention in practice 71.6 27 Anti-PD-L1 scFv-secreting fifth-generation GD2-CAR T cells enhance antitumor function against GD2-low retinoblastoma. Molecular therapy. Nucleic acids 52.1 28 [Surgical treatment of anterior visual pathway gliomas in children using intraoperative neurophysiological monitoring and MR tractography]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 59.24 29 [Desmoplastic infantile gangliogliomas/astrocytomas: clinical course, surgery and morphological diagnosis]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 57.5 30 Donor-source-specific competing risks of relapse and non-relapse mortality in adult B-ALL allogeneic hematopoietic stem cell transplantation on a rabbit antithymocyte globulin-based platform. Annals of hematology 69.12 31 Thoracic Pathologies Requiring Surgical or Interventional Management in Solid-Organ Transplant Recipients. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 69.1 32 Erythema Multiforme after Liver Transplant: A Rare Pediatric Case Report. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 52.3
PATIENT-FRIENDLY SUMMARY

Clinical Profile, Outcomes, and Predictors of Malignant Pheochromocytoma and Paraganglioma: Insights From a Single-Center Cohort.

For education only—not personal medical advice.

Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic